Cargando…
Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization
Bilayer/multilayer tablets have been introduced to formulate incompatible components for compound preparations, but they are now more commonly used to tailor drug release. This research aimed to formulate a novel gastro-retentive tablet to deliver a combination of a fixed dose of two drugs to elimin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858428/ https://www.ncbi.nlm.nih.gov/pubmed/36661809 http://dx.doi.org/10.3390/gels9010043 |
_version_ | 1784874097540333568 |
---|---|
author | Ullah, Ghufran Nawaz, Asif Latif, Muhammad Shahid Shah, Kifayat Ullah Ahmad, Saeed Javed, Fatima Alfatama, Mulham Abd Ghafar, Siti Aisyah Lim, Vuanghao |
author_facet | Ullah, Ghufran Nawaz, Asif Latif, Muhammad Shahid Shah, Kifayat Ullah Ahmad, Saeed Javed, Fatima Alfatama, Mulham Abd Ghafar, Siti Aisyah Lim, Vuanghao |
author_sort | Ullah, Ghufran |
collection | PubMed |
description | Bilayer/multilayer tablets have been introduced to formulate incompatible components for compound preparations, but they are now more commonly used to tailor drug release. This research aimed to formulate a novel gastro-retentive tablet to deliver a combination of a fixed dose of two drugs to eliminate Helicobacter pylori (H. pylori) in the gastrointestinal tract. The bilayer tablets were prepared by means of the direct compression technique. The controlled-release bilayer tablets were prepared using various hydrophilic swellable polymers (sodium alginate, chitosan, and HPMC-K15M) alone and in combination to investigate the percent of swelling behavior and average drug release. The weight of the controlled-release floating layer was 500 mg, whereas the weight of the floating tablets of pantoprazole was 100 mg. To develop the most-effective formulation, the effects of the experimental components on the floating lag time, the total floating time, T 50%, and the amount of drug release were investigated. The drugs’ and excipients’ compatibilities were evaluated using ATR-FTIR and DSC. Pre-compression and post-compression testing were carried out for the prepared tablets, and they were subjected to in vitro characterization studies. The pantoprazole layer of the prepared tablet demonstrated drug release (95%) in 2 h, whereas clarithromycin demonstrated sustained drug release (83%) for up to 24 h (F7). The present study concluded that the combination of sodium alginate, chitosan, and HPMC polymers (1:1:1) resulted in a gastro-retentive and controlled-release drug delivery system of the drug combination. Thus, the formulation of the floating bilayer tablets successfully resulted in a biphasic drug release. Moreover, the formulation (F7) offered the combination of two drugs in a single-tablet formulation containing various polymers (sodium alginate, chitosan, and HPMC polymers) as the best treatment option for local infections such as gastric ulcers. |
format | Online Article Text |
id | pubmed-9858428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98584282023-01-21 Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization Ullah, Ghufran Nawaz, Asif Latif, Muhammad Shahid Shah, Kifayat Ullah Ahmad, Saeed Javed, Fatima Alfatama, Mulham Abd Ghafar, Siti Aisyah Lim, Vuanghao Gels Article Bilayer/multilayer tablets have been introduced to formulate incompatible components for compound preparations, but they are now more commonly used to tailor drug release. This research aimed to formulate a novel gastro-retentive tablet to deliver a combination of a fixed dose of two drugs to eliminate Helicobacter pylori (H. pylori) in the gastrointestinal tract. The bilayer tablets were prepared by means of the direct compression technique. The controlled-release bilayer tablets were prepared using various hydrophilic swellable polymers (sodium alginate, chitosan, and HPMC-K15M) alone and in combination to investigate the percent of swelling behavior and average drug release. The weight of the controlled-release floating layer was 500 mg, whereas the weight of the floating tablets of pantoprazole was 100 mg. To develop the most-effective formulation, the effects of the experimental components on the floating lag time, the total floating time, T 50%, and the amount of drug release were investigated. The drugs’ and excipients’ compatibilities were evaluated using ATR-FTIR and DSC. Pre-compression and post-compression testing were carried out for the prepared tablets, and they were subjected to in vitro characterization studies. The pantoprazole layer of the prepared tablet demonstrated drug release (95%) in 2 h, whereas clarithromycin demonstrated sustained drug release (83%) for up to 24 h (F7). The present study concluded that the combination of sodium alginate, chitosan, and HPMC polymers (1:1:1) resulted in a gastro-retentive and controlled-release drug delivery system of the drug combination. Thus, the formulation of the floating bilayer tablets successfully resulted in a biphasic drug release. Moreover, the formulation (F7) offered the combination of two drugs in a single-tablet formulation containing various polymers (sodium alginate, chitosan, and HPMC polymers) as the best treatment option for local infections such as gastric ulcers. MDPI 2023-01-04 /pmc/articles/PMC9858428/ /pubmed/36661809 http://dx.doi.org/10.3390/gels9010043 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ullah, Ghufran Nawaz, Asif Latif, Muhammad Shahid Shah, Kifayat Ullah Ahmad, Saeed Javed, Fatima Alfatama, Mulham Abd Ghafar, Siti Aisyah Lim, Vuanghao Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization |
title | Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization |
title_full | Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization |
title_fullStr | Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization |
title_full_unstemmed | Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization |
title_short | Clarithromycin and Pantoprazole Gastro-Retentive Floating Bilayer Tablet for the Treatment of Helicobacter Pylori: Formulation and Characterization |
title_sort | clarithromycin and pantoprazole gastro-retentive floating bilayer tablet for the treatment of helicobacter pylori: formulation and characterization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858428/ https://www.ncbi.nlm.nih.gov/pubmed/36661809 http://dx.doi.org/10.3390/gels9010043 |
work_keys_str_mv | AT ullahghufran clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT nawazasif clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT latifmuhammadshahid clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT shahkifayatullah clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT ahmadsaeed clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT javedfatima clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT alfatamamulham clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT abdghafarsitiaisyah clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization AT limvuanghao clarithromycinandpantoprazolegastroretentivefloatingbilayertabletforthetreatmentofhelicobacterpyloriformulationandcharacterization |